sar425899 glp-1 glucagon dual agonist sanofi First clinical PET study measuring the receptor occupancy of a GLP1/ receptor is now published Glucagon-Like Peptide-1 (GLP-1) Agonists: Decreasing

Oral trimetazidine (60 mg/day) taken for three days prior to percutaneous transluminal coronary angioplasty reduced CRP and nitrite levels both at pre- and post-angioplasty and TNF- at post-angioplasty compared to no treatment [162]

Sohail M, Kaul A, Raziuddin M, Adak T

International Clinical Trials Day 2026: inside First-in-Human trials Clinical development begins long before a potential medicine reaches patients

Further treatment strategies are needed to confirm which targets GLS should be combined with for PCa treatment

Deol H, Lekkakou L, Viswanath AK, Pappachan JM

The exploration of these small molecules targeting ferroptosis provides valuable insights into the potential treatment of CKD